The Cancer Problem

The Cancer Problem chronicles the evolution of cancer treatment through the career and experiences of Dr. Vincent DeVita, former director of the National Cancer Institute. DeVita provides an insider's perspective on the major developments in oncology from the 1960s through the present day. DeVita details the scientific breakthroughs, bureaucratic battles, and clinical trials that shaped modern cancer medicine. His narrative follows both the technical advances in treatment methods and the human stories of patients and fellow researchers who influenced the field's direction. The book examines current challenges in cancer research and treatment, including regulatory hurdles, institutional resistance to change, and the complexities of implementing new therapeutic approaches. DeVita outlines potential solutions while documenting ongoing debates within the medical establishment. The work stands as both a medical history and a call to action, highlighting how progress against cancer has often been impeded more by human systems than by scientific limitations. Through personal accounts and case studies, it illustrates the tension between institutional caution and the urgency of patient needs.

There are not enough internet reviews to create a summary of this book. Instead, here is a summary of reviews of Vincent DeVita's overall work: Readers consistently rate DeVita's most prominent book "The Death of Cancer" (co-written with Elizabeth DeVita-Raeburn) highly for its insider perspective on cancer treatment advances. Many readers appreciate his direct explanations of complex medical concepts and personal stories from his career. What readers liked: - Clear explanations of cancer treatment history and development - Behind-the-scenes look at medical research and drug approval processes - Personal accounts of working with patients - Balance of technical detail and accessible writing What readers disliked: - Some found sections about medical politics and bureaucracy too detailed - A few readers noted an occasionally self-congratulatory tone - Technical terminology can be challenging for non-medical readers Ratings: - Goodreads: 4.3/5 from 856 ratings - Amazon: 4.6/5 from 283 reviews Notable reader comment: "DeVita provides unique insight into how cancer treatment evolved, though sometimes gets bogged down in institutional politics." - Goodreads reviewer

The Emperor of All Maladies by Siddhartha Mukherjee A medical history traces cancer research and treatment from ancient Egypt through modern immunotherapy breakthroughs.

The Philadelphia Chromosome by Jessica Wapner The book follows researchers' path to understanding a genetic mutation in leukemia cells which led to targeted cancer treatments.

The Immortal Life of Henrietta Lacks by Rebecca Skloot This work examines how cells taken from a cancer patient in 1951 revolutionized medical research while raising questions about medical ethics and race.

The Death of Cancer by Vincent DeVita The narrative chronicles the development of combination chemotherapy and the evolution of cancer treatment through firsthand accounts of clinical trials.

The Beautiful Cure by Daniel Davis The text presents the history of immunology discoveries and their impact on modern cancer treatments through accounts of laboratory breakthroughs.

🔬 Vincent DeVita served as director of the National Cancer Institute (1980-1988) and helped develop the first successful combination chemotherapy treatment for cancer. 💉 The book reveals how the "War on Cancer," launched by President Nixon in 1971, transformed from a politically-motivated campaign into a genuine scientific revolution. 🏥 DeVita personally treated Jackie Kennedy Onassis for lymphoma and discusses her case, along with other high-profile patients, to illustrate advances in cancer treatment. 📊 The author explains how cancer death rates have dropped 25% since 1991, with more than 2.1 million deaths prevented during that period. 🔋 The book describes how immunotherapy—now considered the "fourth pillar" of cancer treatment alongside surgery, radiation, and chemotherapy—was initially dismissed by most oncologists but has become a breakthrough approach.